On December 21, 2011, Fosun Pharma signed a formal agreement with Shenzhen Belter Health Measurement and Analysis Technology Co., Ltd (Belter). Under the contract, Fosun Pharma will invest RMB44.76 million to Belter, acquiring 11% equity stake.

Belter, founded in 1994 and employs 800 people. It is a state high-tech enterprise incorporating R&D, manufacturing, sales and service, commits itself to R&D and promotion of healthy, nutritional, sports and human health measurement products and interactive network platform, takes remote medical service via online HD videos so as to provide complete health solutions for users. In 2011, it successfully entered into medical informationization industry.

Following the concept of “leading a new health model” and sticking to professional development, the company positions itself as a first-class manufacturer of human health data acquisition terminal and a first-class operator of integrated health service platform. Through more than a decade of entrepreneurship and development, depending on business covering over 30 provinces and 60 foreign countries and regions, Belter has grown to a company with certain scale and strength and taken the lead in the industry.
Belter has been certified with ISO9001, EU CE and ROHS and ISO13485.

Over the past years, focused on independent R&D and technological innovation, the company has owned a number of technological inventions and patents and dozens of utility patents, especially granted patents in network-based health information acquisition. In 2011, Belter made great achievements in new products R&D and manufacturing, including health pavilion, the regional medical information terminal co-developed and manufactured with Huawei, a series of network-based health measurement products co-developed and manufactured with Skyworth to fit with Kukang TV and Beikang Instrument, the multi-parameter health measurement product developed and manufactured by itself. Previously, medical informationization was focused on the informationization of medical institutions, while these products can make the informationization of people’s healthcare into a reality. 

Yao Fang, President of Fosun Pharma said that Fosun Pharma is optimistic about Belter’s professional experience and market advantages in the medical informationization. I believe that we can help Belter step into a fast track for growth with our advantageous resources in strategy, management and channel. (Xiang Dejun)